Squarepoint’s Compugen CGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-171,544
Closed -$252K 4331
2025
Q3
$252K Sell
171,544
-27,456
-14% -$40.8K ﹤0.01% 3795
2025
Q2
$354K Sell
199,000
-101,036
-34% -$150K ﹤0.01% 3558
2025
Q1
$438K Buy
300,036
+9,377
+3% +$18.3K ﹤0.01% 3427
2024
Q4
$445K Buy
290,659
+123,641
+74% +$201K ﹤0.01% 3823
2024
Q3
$302K Buy
167,018
+81,325
+95% +$148K ﹤0.01% 3439
2024
Q2
$144K Buy
85,693
+16,253
+23% +$33.9K ﹤0.01% 3733
2024
Q1
$179K Buy
+69,440
New +$162K ﹤0.01% 3641
2022
Q4
Sell
-12,826
Closed -$8K 3212
2022
Q3
$8K Buy
12,826
+1,926
+18% +$2.72K ﹤0.01% 2925
2022
Q2
$20K Buy
+10,900
New +$23.5K ﹤0.01% 2771
2022
Q1
Sell
-47,688
Closed -$205K 2891
2021
Q4
$205K Sell
47,688
-27,488
-37% -$149K ﹤0.01% 2684
2021
Q3
$449K Sell
75,176
-69,519
-48% -$466K ﹤0.01% 2023
2021
Q2
$1.2M Buy
144,695
+123,365
+578% +$1M ﹤0.01% 1506
2021
Q1
$183K Buy
+21,330
New +$237K ﹤0.01% 2729
2020
Q4
Sell
-66,228
Closed -$1.08M 2952
2020
Q3
$1.08M Buy
+66,228
New +$1.09M 0.01% 950

Other funds holding CGEN

Squarepoint's CGEN Position: Q4 2025 in Review

Squarepoint sold out of Compugen (CGEN) in Q4 2025, closing a stake of 171,544 shares — an estimated $252K sold.

Squarepoint first reported a position in CGEN in Q3 2020 and held it in 14 quarters. The position peaked at $1.2M in Q2 2021. 72 funds tracked by Wall St. Rank hold CGEN as of Q4 2025.

  • Squarepoint reported no remaining Compugen position as of Q4 2025 after selling out during the quarter.
  • Squarepoint sold 171,544 Compugen shares in Q4 2025, an estimated $252K.
  • Squarepoint first reported a position in Compugen in Q3 2020 and held it in 14 quarters.
  • Squarepoint's Compugen position peaked at $1.2M in Q2 2021.
  • 72 funds tracked by Wall St. Rank held Compugen as of Q4 2025.

Based on Squarepoint's 13F filing for Q4 2025, filed 13 Feb 2026.